Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jan 27, 2009


Gentel Biosciences has promoted Randall Durnell to executive vice president and chief operating officer, the firm said this week. Dan Clutter has been hired to fill the vice president of commercial operations role vacated by Durnell. Clutter joins Gentel from Roche NimbleGen, where he served as vice president of sales.

Prior to NimbleGen in 2004, Clutter held sales and marketing positions at several companies, including PerkinElmer, Invitrogen, and Applied Biosystems. He holds a PhD from Pennsylvania State University and a BS in biochemistry from Purdue University.

Scott Gottlieb, former US Food and Drug Administration deputy commissioner, has joined the board of directors of CombiMatrix. Gottlieb is currently a resident fellow at the American Enterprise Institute and also serves as an attending physician at Stamford Hospital.

Luminex last week said that executive VP and COO Douglas Bryant recently stepped down from his job in order to become president and CEO of diagnostics firm Quidel in San Diego.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.